Concepedia

Shilpi Khare

SK

Statistics

Publications

11

Citations

1.4K

H-Index

11

Active since

2001

Affiliations

University of California, Los Angeles(Current)

Genomics Institute of the Novartis Research Foundation

University of California San Diego

Novartis Institutes for BioMedical Research

Novartis (Switzerland)

Shilpi Khare is an author at University of California, Los Angeles specializing in life sciences, protozoan host-parasite interactions, and enzyme inhibition.

Publications per year

2001–2020

11

Publications

11

The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells

Zhen Lü, Robert Z. Luo, Yiling Lu et al. · Journal of Clinical Investigation · 2008 · 458 citations · Full text

, , +17

Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness

Shilpi Khare, A. S. Nagle, Agnes Biggart et al. · Nature · 2016 · 420 citations · Full text

, , +16

Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases

A. S. Nagle, Agnes Biggart, C. Be et al. · Journal of Medicinal Chemistry · 2020 · 117 citations · Full text

, , +14

Diabetes reversal by inhibition of the low-molecular-weight tyrosine phosphatase

Stephanie M. Stanford, Alexander E. Aleshin, Vida Zhang et al. · Nature Chemical Biology · 2017 · 73 citations · Full text

, , +11

Utilizing Chemical Genomics to Identify Cytochrome b as a Novel Drug Target for Chagas Disease

Shilpi Khare, Steven L. Roach, S. Whitney Barnes et al. · PLoS Pathogens · 2015 · 68 citations · Full text

, , +16

1–5 of 11